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A B ST R AC T 
 
 
Epidermolysis bullosa (EB) is a rare, serious genetic disease, incurable 
through the current means. Apart from this initial definition, there was 
later some ease in the definition of the disease, including the 
manifestations of toxic epidermal necrolysis and Stevens Johnson 
syndrome in this entity. In medical practice, there are cases that do not 
overlap with the description in the literature, thus the treatment must be 
adapted and personalized to the particularities. We present the case of a 
female new-born, with "de novo" mutation for the early-onset antenatal 
epidermolysis and our personalized therapeutic management, based on 
collagen from bovine corneas by enzymatic process. The histological 
examination showed that the collagen membranes serve as a support for 
the epithelial cells that formed a surface monolayer after 48 hours. 
Therefore. this case report shows that collagen-based biomaterials could 
be used to accelerate the dermal-epidermal healing in various conditions 
of the child, such as Stevens Johnson syndrome, bullous epidermolysis 
and widespread burns.   
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Epidermolysis bullosa is a rare condition, with genetic 
determinism, affecting less than 5 patients in 10,000 people 
in Europe [1]. There is a polymorphism of the clinical 
forms, the spectrum of manifestations varying from mild to 
serious forms and the basic pathophysiological mechanism 
consists in the exaggerated fragility of the intercellular 
connections with the appearance of cleavage planes that 
determine the occurrence of blisters on the skin and 
mucous membranes in response to heat, local pressure, and 
friction. 
The term "epidermolysis bullosa" actually comprises a 
heterogeneous group of over 25-30 vesicular hereditary 
disorders that have been classified according to the level at 
which the cleavage occurs and the blisters appear, as 
follows [2]: 
1. The epidermolytic form (cleavage of keratinocytes 
with autosomal dominant, recessive or x-linked 
transmission); 
2. The dermolytic (or dystrophic) form cleavage in 
superficial dermal papillae and autosomal dominant or 
recessive transmission; 
3.  The mixed form (Kindler syndrome). 
Genetically, the mutations described are diverse:  
• Autosomal dominant, recessive or x-linked intra-
epithelial forms with loci in regions 8q24, 12q13, 17q12-
q21, Xq 27-3qter; 
• Junctional forms show autosomal recessive mutations 
in the region 1q31, 1q32, 1q25-q31, 10q24-3, 17q11-qter, 
18q 11.2; 
• The dermolytic forms are due to dominant or recessive 
mutations of the α1 polypeptide gene VII (COL7A) that 
determine collagen synthesis and are located in the region 
3p 21.3. There are “de novo” mutations due to genes of 
unknown location. 
According to the literature, the onset is immediately 
after birth, which can affect the skin of the whole body, as 
well as the mucous membranes, and trigger factors can be 
minor, such as: hits, scratches, even more energetic 
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touches. The repercussions are reducible, joint damage 
occurs, periodontitis, edentation, nail damage, sclerosis, 
severe protein and mineral deficiency [3]. 
Case presentation 
We present the case of a "de novo" mutation for the 
early-onset antenatal epidermolysis. The female child, 
from a carefully monitored clinical and ultrasound 
pregnancy, was born at the gestational age of 39 weeks. 
There was nothing suggestive in the family health history, 
both parents and the 2-year-old brother being absolutely 
healthy. As additional information, the feeding of the 
whole family, implicitly of the mother of the child during 
the antepartum period, is made with foods from strictly 
biological cultures, being very balanced in nutritional 
principles. The mother did not show any pathology during 
pregnancy. The only special mention was regarding the 
stress perceived by the mother during pregnancy, in part 
related to the COVID-19 pandemic. At the time around the 
birth, all the regulations regarding the prevention of intra-
hospital dissemination of the Sars-Cov-2 infection were 
respected according to the protocols, including social 
distancing, facial mask wearing and frequent cleaning and 
disinfection of the surfaces [4-6]. The mother was tested 
negative for Sars-Cov-2 before admission. The postnatal 
adaptation was good, W = 3,200 g, balanced cardio-
respiratory, spontaneous motions, intestinal tract present. 
In the first 12 hours postpartum, in the lumbar region, 
buttock, and at the level of the upper limbs, blistering 
lesions that break appeared, revealing large areas of dermis 
(Figure 1).  
 
Figure 1. The blistering lesions 
Due to the high septic risk, considering that in the first 
24 hours about 50% of the area was affected, the decision 
to transfer the child to NICU for supervision and care was 
made. The hospitalization lasted for 40 days, during 
which time local antiseptic solutions were applied, along 
with hydration baths, emollients, local dressings, 
treatment for hydro electrolytic disorder and broad-
spectrum antibiotics (meronem). During the 
hospitalization period, the blistering lesions occurred at 
the level of the entire skin, including at the level of the 
buccal mucosa, except for the hairy area of the head.  
After discharge, at the age of 42 days, W=3,240g, the 
child receives home care recommendation for new and old 
lesions. During the 8-month period, new lesions are 
present, especially in the frictional areas. Two lesions 
resulted in keloid scars and there were many recurrences in 
the respective areas (region of the gluteal crease). At 9 
months of age, the child has a severe degree of dystrophy 
(W = 5,700g, without being associated with psychomotor 
retardation) (Figures 2-4).  
 
Figure 2. Early lesions in the gluteal region 
 
Figure 3. Advanced lesions in the gluteal region 
 
Figure 4. Healing lesions 
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Complementary examinations "targeted" on the 
condition (bullous epidermolysis) were performed. At the 
histological examination of the lesion, it was found that the 
intercellular connections in the normal integumentary 
architecture were altered by changes in collagen structures. 
Karyotyping of the child and parents (performed at a 
specialized institute in the UK) has not established genetic 
mutations, the diagnosis made by experts being "transient 
epidermolysis bullosa". 
Blood tests revealed a significant degree of anemia 
(Hb: 9.7g/dl with serum iron ~ 18 μg%), hypoalbuminemia 
(2.9g/dl), hypocalcemia (7.9g/dl) and cultures from the 
superinfected lesions from the gluteal crease determined 
the presence of Pseudomonas aeruginosa. 
A peculiarity of the case is that the child is still 
breastfed, has no respiratory or digestive intercourse and 
the complementary food has been extremely deficient 
without high animal protein (meat, egg) and the diet is 
deficient, of the lactovegetarian type. 
The diagnosis of the child at 9 months is: epidermolysis 
bullosa, secondary pyodermal infection (pseudomonas), 
malnutrition II/III, iron deficiency, anemia, hypocalcemia. 
The follow-up and dispensation of the case is lasting for 
the chronic underlying disease (epidermolysis) and for the 
associated conditions (malnutrition, anemia). The hygiene 
rules are very strict, the disinfection and the continuous 
dressing of the injuries being mandatory. Nutrition 
recovery depends on the family's compliance, which 
unfortunately is supportive of restrictive diets. 
The literature establishes that, depending on the 
severity of the disease, after the healing of the bullous 
lesions, keloid scars may occur, some of them mutilating, 
with limbs or segments in flexion, hair loss, nails, teeth, 
(temporary) impaired vision depending on the location of 
the typical lesions. 
A unique feature of the case, in total discrepancy with 
the data in the literature, is the "failure to agree" to the 
early, antenatal onset of the severe postnatal evolution of 
the lesions with the lack of genetic modifications and to 
make the diagnosis of a "transient" form after karyotyping. 
This case highlights the importance of the signed informed 
consent, after presenting all possible incidents and 
complications, as well as the therapeutic alternatives, this 
being an important element in building a strong and 
confident patient-doctor relationship, increase adherence 
to treatment and prevent the possible medical errors [7,8]. 
Therapeutic options and decisions in our case 
Type I collagen was prepared from bovine corneas by 
enzymatic processes, using pepsin (Merck) in acetic acid 
medium. For the solution obtained, the collagen content 
was determined by hydroxyproline (Hyp) dosage, 
according to the modified Woesneer method and the 
content in hexozoamines (by the Elson Morgan method). 
GAG (KS-keratan sulfate mixture) and CS (chondroitin 
sulfate) were extracted from the same corneal tissue by 
papain enzymatic method and purified by ion exchange 
chromatography and ethanol precipitation. The 
composition of the GAG mixture was determined by 
measuring uronic acids (for CS) and neutral carbohydrates 
(for KS). 
Membrane preparation: Type I collagen solution was 
diluted with 0.5M acetic acid to a final concentration of 
0.4 % (g/g) and dialyzed relative to distilled water to its 
pH. 
The GAG mixture, containing two parts KS and one CS 
was dissolved in distilled water at a concentration of 0.85 
and added to the collagen solution, through continuous 
stirring. 
Variants of COL-GAG (collagen-glycosaminoglycan) 
solutions in ratio 1: 1, 2: 1, 4: 1, 7: 7 and 10: 1 were 
prepared. The COL type I solution and COL-GAG 
composition were dried as a membrane by evaporation of 
the solvent at 35°C for 48 hours. 
COL-GAG sponges were prepared identically to the 
membranes, with the exception that the dilution was made 
at a concentration of 0.8% (g/g). The drying of the COL-
GAG composition was carried out by lyophilization, for 72 
hours, obtaining elastic white foam foils. 
The sponges based on fibrillary collagen and gelatin 
(COL F-Gel) were obtained according to the following 
procedure (Figure 5): 
 
Figure 5. The procedure used to obtain sponges based 
on fibrillar collagen and gelatin 
A stabilized line of calf kidney epithelial cells was 
introduced into Petri culture vessels in contact with 
collagen membranes and sponges at 37°C for 96 hours. The 
histological examination showed that the collagen 
membranes serve as a support for the epithelial cells that 
formed a surface monolayer after 48 hours after 
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cultivation. At 96 hours of culture, the cells had a normal 
appearance (Figures 6, 7). 
 
Figure 6. Optical microscopy images of epithelial 
cells grown on collagen membranes, 40 hours 
 
Figure 7. Optical microscopy images of epithelial 
cells grown on collagen membranes, 96 hours 
Regarding the collagen sponges at 48 hours, cells were 
observed only on their surface, and at 96 hours, cells 
penetrated into the three-dimensional network structure 
and attached to the alveolar structure (much better in COL-
GAG structures compared to COL) (Figures 8, 9). 
 
Figure 8. Epithelial cells grown on sponge by COL-
GAG. After 96 hours, the cells migrated inside the 
sponge and attached to its alveolar structure    
   
 
Figure 9. Epithelial cells grown 96 hours on the 
COL F-Gel sponge 
Discussions 
From the point of view of the clinical manifestations, 
certain types of dystrophic epidermolysis (EB) have been 
described, along with the most frequent type of multiple 
forms of epidermolysis [9]. 
1. Hallopeau-Siemens autosomal recessive EB - the 
most severe form, with congenital blisters on a large 
percentage of the body surface and sometimes with 
portions absent from the integument (caused by traumas 
during birth). The blisters also affect the mucous 
membranes, subsequently causing integumentary scarring 
in the digestive tract (esophagus, buccal cavity) as well, 
thus leading to significant complications: post-keloid scar 
contraction, fusion of fingers, nail disappearance, eye 
inflammation, chronic malnutrition. On the long term, 
there is an increased risk of squamous, lethal carcinoma. 
2. Autosomal recessive non-Hallopeau-Siemens EB - 
the blisters are usually more limited on the hands and feet 
(elbows, knees), post-bulging scars occur, not very 
mutilating, as well as nail malformative changes. 
3. Autosomal dominant EB is the mildest form of EB, 
the blisters are usually confined to the hands, feet, knees, 
elbows. 
In less severe situations, abnormal nail growth is the 
only sign of the disease. In recent years, epigenetic causes 
have been most frequently discussed, as being incriminated 
in the action of the gene switch, which activates certain 
genes or suppresses the action of others, thus transforming 
them into dormant genes. 
The generic known period of 1,000 days is defining in 
the development of a child. It practically starts at the time 
of conception and ends after 2 years of life. Excluding a 
multitude of triggering factors (diet, medicines, nuisances, 
etc.) special attention is paid to maternal stress during the 
antepartum period [10,11]. 
There has been a study for a period of 13 years (see 
book "1,000 days"), which shows an increase of cortisol (as 
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a stress hormone) during the antepartum period, during 
pregnancy, postpartum, associated with the increase of 
cortisol in the newborn and remote effects, including a 
change in neuroplasticity. Affected children showed an 
increase in the stress level and a decrease in adaptation to 
the beginning of the new school year or to public speaking 
[12,13]. 
In addition, stressors (e.g., noise, light) applied to 
batches of laboratory mice caused atopic dermatitis lesions, 
with changes in the rate of cell regeneration and in normal 
cellular architecture. Collagen, as a biomaterial component 
and support, has been recently used in medicine more and 
more often. Its properties have been exploited, such as the 
behavior of biological dressing and the non-stick and anti-
adherence qualities [14-17]. 
In recent years, nutrition has been underlined as an 
important trigger of bullous skin diseases [18]. The wound 
management has been under debate in order to reach a 
consensus [19]. The physiological disappearance of the 
provisional matrix of a clot is as important as its formation. 
The inadequate removal of fibrin may interfere with the 
normal process of wound healing [20,21].  
This study shows that biomaterials based on COL and 
GAG may be a possible future solution, at least in patients 
with extensive epithelial disorders (epidermolysis, Steven-
Johnson syndrome, severe burns, corneal lesions and so on) 
[22,23]. 
Highlights 
✓ Epidermolysis bullosa is a rare condition with genetic 
determinism, with a significant polymorphism of the 
clinical forms. 
✓ The follow-up should carefully monitor the cutaneous 
mucosal relapses, the growth and development of the 
child and the possible sequelae. 
✓ Shortening the healing time with collagen membranes 
will reduce the risk of further septic complications, 
dehydration and hydro-electrolytic imbalance. 
Conclusions 
In conclusion, the presented case has the following 
features: early onset (antenatal), lack of possible triggering 
factors in the mother (except for stressful periods), lack of 
changes in the genetic karyotype, severity of the skin 
condition, association of deficient conditions 
(malnutrition, anemia, rickets). 
Although diagnosed with the "mild" form from a 
genetic point of view, the evolution is autosomal recessive 
Hallopeau-Siemens type EB. The evolution will have to be 
carefully monitored in terms of cutaneous mucosal 
relapses, the growth and development of the child and of 
the possible sequelae. 
Collagen-based biomaterials can be used to accelerate 
dermal-epidermal healing in various conditions of the child 
(Stevens Johnson syndrome, bullous epidermolysis, 
widespread burns). Shortening the healing time with 
collagen membranes will reduce the risk of further 
complications: septic - infections, hydro electrolytic - 
dehydration.  
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